Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Prostatic Neoplasms × dexamethasone acetate × Clear all

Phase

Phase NA 1 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Multiple Myeloma 31 Burkitt Lymphoma 11 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Lymphoma, Mantle-Cell 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma 3 Leukemia, Biphenotypic, Acute 3 Immunoglobulin Light-chain Amyloidosis 3 Smoldering Multiple Myeloma 2 Recurrence 2 Neoplasms, Plasma Cell 2 Neoplasms 2 Brain Neoplasms 2 Blast Crisis 2 Renal Insufficiency 1 Prostatic Neoplasms 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Plasmacytoma 1 Neoplasm Metastasis 1 Meningioma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, B-Cell, Marginal Zone 1 Lung Neoplasms 1 Leukemia, Plasma Cell 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia 1 Hodgkin Disease 1

Interventions

Docetaxel 137 Prednisone 120 Abiraterone Acetate 91 Leuprolide 86 enzalutamide 83 Radiotherapy 58 bicalutamide 55 Magnetic Resonance Spectroscopy 54 Goserelin 54 Androgen Antagonists 51 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 47 apalutamide 44 abiraterone 34 Radiosurgery 32 Specimen Handling 30 gallium 68 PSMA-11 29 Gonadotropin-Releasing Hormone 29 cabazitaxel 28 Carboplatin 28 darolutamide 25 Estramustine 24 luprolide acetate gel depot 23 relugolix 22 Metformin 22 Triptorelin Pamoate 20 sipuleucel-T 19 radium Ra 223 dichloride 19 Radiation 19 pembrolizumab 18 deltacortene 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00427999 2016-11-21

INV342

Novartis

Phase 2 Completed

67 enrolled 6 charts

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡